OBESE ADULT PARTICIPANTS AT RISK OF CARDIOVASCULAR DISEASE

Clinical trials for OBESE ADULT PARTICIPANTS AT RISK OF CARDIOVASCULAR DISEASE explained in plain language.

Never miss a new study

Get alerted when new OBESE ADULT PARTICIPANTS AT RISK OF CARDIOVASCULAR DISEASE trials appear

Sign up with your email to follow new studies for OBESE ADULT PARTICIPANTS AT RISK OF CARDIOVASCULAR DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New drug ISM8969 begins first human safety tests

Knowledge-focused Not yet recruiting

This early-phase study tests the safety and tolerability of a new oral drug called ISM8969 in healthy adults, elderly adults, and obese adults at risk for heart disease. About 100 participants will receive either the drug or a placebo to check for side effects and how the drug mo…

Matched conditions: OBESE ADULT PARTICIPANTS AT RISK OF CARDIOVASCULAR DISEASE

Phase: PHASE1 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Knowledge-focused

Last updated May 22, 2026 13:51 UTC

OBESE ADULT PARTICIPANTS AT RISK OF CARDIOVASCULAR DISEASE

Get alerted when new OBESE ADULT PARTICIPANTS AT RISK OF CARDIOVASCULAR DISEASE trials appear

New drug ISM8969 begins first human safety tests